Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 3
1965 1
1973 1
1974 7
1975 40
1976 68
1977 95
1978 61
1979 99
1980 93
1981 80
1982 105
1983 125
1984 110
1985 83
1986 106
1987 69
1988 72
1989 60
1990 74
1991 75
1992 65
1993 87
1994 93
1995 83
1996 97
1997 89
1998 80
1999 117
2000 130
2001 146
2002 151
2003 176
2004 176
2005 174
2006 162
2007 208
2008 200
2009 189
2010 211
2011 244
2012 217
2013 189
2014 201
2015 217
2016 168
2017 145
2018 147
2019 126
2020 149
2021 129
2022 77
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

5,507 results
Results by year
Filters applied: . Clear all
Page 1
Vidarabine is neither a potent nor a selective AC5 inhibitor.
Seifert R. Seifert R. Biochem Pharmacol. 2014 Feb 15;87(4):543-6. doi: 10.1016/j.bcp.2013.12.025. Epub 2014 Jan 4. Biochem Pharmacol. 2014. PMID: 24398424 Review.
Therefore, vidarabine has been suggested to mediate these effects via selective inhibition of AC5. ...Here, evidence is presented that vidarabine is neither a potent nor a selective AC5 inhibitor. Greatest caution should be exerted when proposing new mechanisms of a …
Therefore, vidarabine has been suggested to mediate these effects via selective inhibition of AC5. ...Here, evidence is presented tha …
Vidarabine (Vira-A).
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1977 May 20;19(10):42-3. Med Lett Drugs Ther. 1977. PMID: 323676 Clinical Trial. No abstract available.
Vidarabine encephalopathy.
Cullis PA, Cushing R. Cullis PA, et al. J Neurol Neurosurg Psychiatry. 1984 Dec;47(12):1351-4. doi: 10.1136/jnnp.47.12.1351. J Neurol Neurosurg Psychiatry. 1984. PMID: 6512557 Free PMC article.
Vidarabine (adenine arabinoside, ara-a) has been found to be useful in the treatment of various viral infections. Its adverse neurological effects include tremor and encephalopathy. Two cases of vidarabine encephalopathy are reported and the five other cases in the
Vidarabine (adenine arabinoside, ara-a) has been found to be useful in the treatment of various viral infections. Its adverse neurolo
Vidarabine: a preliminary review of its pharmacological properties and therapeutic use.
Whitley R, Alford C, Hess F, Buchanan R. Whitley R, et al. Drugs. 1980 Oct;20(4):267-82. doi: 10.2165/00003495-198020040-00002. Drugs. 1980. PMID: 6998693 Review.
Vidarabine is the first drug to become generally available in the USA for parenteral treatment of life-threatening or debilitating herpes simplex virus infections of man. ...
Vidarabine is the first drug to become generally available in the USA for parenteral treatment of life-threatening or debilitating he
Toxicity of vidarabine.
Sacks SL, Smith JL, Pollard RB, Sawhney V, Mahol AS, Gregory P, Merigan TC, Robinson WS. Sacks SL, et al. JAMA. 1979 Jan 5;241(1):28-9. doi: 10.1001/jama.1979.03290270020010. JAMA. 1979. PMID: 758490 No abstract available.
Vidarabine for herpes zoster.
Topiel MS, Simon GL. Topiel MS, et al. N Engl J Med. 1983 Mar 3;308(9):526-7. N Engl J Med. 1983. PMID: 6823274 No abstract available.
Synthesis and antiviral effect of phosphamide modified vidarabine for treating HSV 1 infections.
Wang Z, Zang R, Niu Z, Wang W, Wang X, Tang Y. Wang Z, et al. Bioorg Med Chem Lett. 2021 Nov 15;52:128405. doi: 10.1016/j.bmcl.2021.128405. Epub 2021 Oct 6. Bioorg Med Chem Lett. 2021. PMID: 34624489
Vidarabine (ARA) was one of the earliest marine-related compounds to be used clinically for antiviral therapy, however, its fast metabolism is the main defect of this drug. ...
Vidarabine (ARA) was one of the earliest marine-related compounds to be used clinically for antiviral therapy, however, its fast meta
Vidarabine-associated encephalopathy and myoclonus.
Vilter RW. Vilter RW. Antimicrob Agents Chemother. 1986 May;29(5):933-5. doi: 10.1128/AAC.29.5.933. Antimicrob Agents Chemother. 1986. PMID: 3729352 Free PMC article.
A 24-year-old man with disseminated herpes zoster, which occurred 9 months after bone marrow transplantation for chronic myeloid leukemia, developed encephalopathy and immobilizing myoclonus after 7 days of vidarabine treatment (10 mg/kg of body weight per day). Only mild …
A 24-year-old man with disseminated herpes zoster, which occurred 9 months after bone marrow transplantation for chronic myeloid leukemia, d …
Vidarabine-loaded nanoparticles: a physicochemical study.
Guise V, Drouin JY, Benoit J, Mahuteau J, Dumont P, Couvreur P. Guise V, et al. Pharm Res. 1990 Jul;7(7):736-41. doi: 10.1023/a:1015819706491. Pharm Res. 1990. PMID: 2395802
The chemical reaction of vidarabine (VIDA) with isohexyl cyanoacrylate nanoparticles in a pH-dependent fashion occurs only in the presence of dioctylsulfosuccinate (DOSS). ...
The chemical reaction of vidarabine (VIDA) with isohexyl cyanoacrylate nanoparticles in a pH-dependent fashion occurs only in the pre …
Vidarabine ophthalmic ointment (Vira-A).
[No authors listed] [No authors listed] Drug Ther Bull. 1979 May 25;17(11):43-4. Drug Ther Bull. 1979. PMID: 467237 No abstract available.
5,507 results